Yüklüyor......
Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications
Schizophrenia affects approximately 1% of the population and continues to be associated with poor outcome because of the limited efficacy of and noncompliance with existing antipsychotic medications. An alternative hypothesis invoking the excitatory neurotransmitter, glutamate, arose out of clinical...
Kaydedildi:
| Yayımlandı: | Handb Exp Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4817347/ https://ncbi.nlm.nih.gov/pubmed/23027419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-3-642-25758-2_10 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|